Development and External Validation of a Multivariable Predictive Model for Progression to Difficult‐to‐Treat Rheumatoid Arthritis in Biologic‐Experienced Patients

Our model demonstrated moderate discrimination and calibration, highlighting the challenge in accurately predicting D2T-RA outcomes. These findings underscore the need for further research to improve predictive performance, potentially through the incorporation of additional biomarkers.